1. Recent advances in neuro-ophthalmology
- Author
-
Shikha T Bassi, Nancy J Newman, John J Chen, Nanthaya Yui Tisavipat, Susan P Mollan, Heather E Moss, and Dan Milea
- Subjects
artificial intelligence ,aqp4 antibody ,collapsin response mediator protein 5 antibody ,gene therapy ,giant cell arteritis ,glial fibrillary acidic protein antibody ,myelin oligodendrocyte glycoprotein antibody ,optical coherence tomography ,teleophthalmology ,teprotumumab ,thyroid eye disease ,tocilizumab ,Ophthalmology ,RE1-994 - Abstract
This review article represents a collaborative effort across continents, bringing together the latest developments in neuro-ophthalmology with a focus on innovative diagnostic and therapeutic modalities that are shaping the future of the field. Among the most significant advancements is the rise of optical coherence tomography (OCT), now recognized as an indispensable tool in neuro-ophthalmological research, providing unparalleled insights into optic nerve and central nervous system pathologies. Gene therapy, particularly for conditions such as Leber's hereditary optic neuropathy, marks a new frontier in personalized medicine, offering hope for previously untreatable conditions. The article also examines the transformative role of telemedicine and artificial intelligence (AI) in clinical practice, which are revolutionizing patient care and enhancing diagnostic precision. Furthermore, it highlights the impact of novel serological biomarkers on the understanding and management of immune-mediated optic neuritis, and discusses the introduction of new therapeutic agents like Tocilizumab and Teprotumumab, which are redefining treatment paradigms. Collectively, these advancements reflect the profound influence of modern medicine on neuro-ophthalmology, paving the way for improved patient outcomes and fostering new avenues for research and clinical practice.
- Published
- 2024
- Full Text
- View/download PDF